Wollongong Hospital is the major tertiary referral hospital located in the Wollongong Metropolitan area, New South Wales, Australia. It provides services to the entire Illawarra and Shoalhaven Region, encompassing population of approximately 350,000.

During the past decade, Wollongong Hospital conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 10 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 6 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wollongong Hospital" #1 sponsor was "Celgene" with 9 trials, followed by "Australian and New Zealand Intensive Care Research Centre" with 5 trials sponsored, "University of Sydney" with 5 trials sponsored, "The George Institute" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wollongong Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 8 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 4 trials as a collaborator, "Australasian Society for Infectious Diseases" with 3 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 3 trials as a collaborator and "Cancer Trials Ireland" with 3 trials as a collaborator. Other collaborators include 90 different institutions and companies that were collaborators in the rest 83 trials.

According to Clinical.Site data, the most researched conditions in "Wollongong Hospital" are "Multiple Myeloma" (4 trials), "Crohn Disease" (3 trials), "Myelodysplastic Syndromes" (3 trials), "Atrial Fibrillation" (2 trials) and "Bloodstream Infections" (2 trials). Many other conditions were trialed in "Wollongong Hospital" in a lesser frequency.

Most popular intervention types in "Wollongong Hospital" are "Drug" (49 trials), "Other" (15 trials), "Radiation" (8 trials), "Procedure" (6 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Lenalidomide" (4 trials), "Ozanimod" (3 trials), "Azacitidine" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wollongong Hospital" are 60 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Wollongong Hospital". undefined are not yet recruiting, 20 are recruiting, 14 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 18 completed trials in Wollongong Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Wollongong Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 12 trials that are defined as “Not Applicable".